Press Releases

Date Title and Summary Additional Formats
Toggle Summary Streamline Health® Reports Fiscal First Quarter 2023 Financial Results
First quarter fiscal 2023 SaaS revenue up 12% compared to first quarter fiscal 2022 $17.8 million of Booked SaaS ACV as of April 30, 2023 compared to $17.2 million as of January 31, 2023 ; $12.7 million of Booked SaaS ACV implemented as of April 30, 2023 Atlanta, GA , June 12, 2023 (GLOBE NEWSWIRE)
View HTML
Toggle Summary Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2021 Financial Results
Fourth Quarter Revenues of $ 6.0   M illion;  1 55 % SaaS Revenue Growth ;   $30,000 in Net Loss;   ( $ 0.3)   M illion in Adjusted EBITDA Atlanta, GA , April 27, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“ Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of
View HTML
Toggle Summary Streamline Health® Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results
Fiscal 2022 SaaS revenue up 53% vs fiscal 2021 Total contract value of fiscal 2022 SaaS bookings was $22.4 million compared to $5.6 million in fiscal 2021 Reported $17.2 million of Booked SaaS ACV as of January 31, 2023 , compared to $10.6 million as of January 31, 2022 Executed strategic alignment
View HTML
Toggle Summary Streamline Health® Reports Fiscal Second Quarter 2022 Financial Results
10 9 % Year-Over-Year Increase in Second Quarter Revenues to  $ 6.0   M illion;  138 % SaaS Revenue Growth ;   $ 4.4 Million in New SaaS Bookings Atlanta, GA , Sept. 07, 2022 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of
View HTML
Toggle Summary Streamline Health® Reports Fiscal Second Quarter Financial Results
1 3 % growth of SaaS revenue in the first half of fiscal 2023 compared to the first half of fiscal 2022 Atlanta, GA , Sept. 13, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc.   (“Streamline” or the “Company”) (Nasdaq: STRM) , a leading provider of solutions that enable healthcare
View HTML
Toggle Summary Streamline Health® Reports Fiscal Third Quarter 2021 Financial Results
Revenues of $ 5.5   M illion;  214 % SaaS Revenue Growth ;   $(4.3) Million Net Loss;   $(0.3)   M illion   Adjusted EBITDA Atlanta, GA , Dec. 08, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“ Streamline” or the “Company”) (Nasdaq: STRM), provider of the eValuator ™ Revenue
View HTML
Toggle Summary Streamline Health® Reports Fiscal Third Quarter 2022 Financial Results
Total contract value of SaaS bookings for the nine months ended October 31, 2022 was $14.1 million compared to $3.9 million during the same period of fiscal 2021 Strengthened balance sheet with recent capital raise of $8.3 million Third quarter 2022 SaaS revenue up 14% vs.
View HTML
Toggle Summary Streamline Health® Reports Fiscal Third Quarter 2023 Financial Results
22% growth of SaaS revenue in the third quarter of fiscal 2023 compared to the third quarter of fiscal 2022 $400 thousand of Adjusted EBITDA generated in the third quarter of fiscal 2023 compared to ($1.2) million during the third quarter of fiscal 2022 $13.0 million of Booked SaaS ACV as of
View HTML
Toggle Summary Streamline Health® Reports Fourth Quarter 2014 Revenues Of $6.6 Million; 2014 Recurring Revenues Of 88%
New CEO to Focus on Revenue Growth and Looking Glass® Platform to Improve Financial Performance in 2015 and BeyondCompany to Provide 2015 Guidance During Earnings Call
View HTML
Toggle Summary Streamline Health® Reports Fourth Quarter And Fiscal Year 2015 Financial Performance
Fourth Quarter Revenues $6.4 Million; $9.9 Million Cash on Hand; FY 2015 Revenues $28.3 Million; $5.9 Million in Cash from Operations; 2015 Adjusted EBITDA $2.8 Million; $5.6 million Net Loss
View HTML